ADMA operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Adma Biologics Inc Operating Expenses — Trailing twelve months (TTM) (USD)
Period ending	Operating Expenses (USD)
Jun 30, 2026	114,912,000
Mar 31, 2026	105,509,000
Dec 31, 2025	101,324,000
Sep 30, 2025	100,269,000
Jun 30, 2025	95,676,000
Mar 31, 2025	89,499,000
Dec 31, 2024	80,570,000
Sep 30, 2024	72,413,186
Jun 30, 2024	68,360,186
Mar 31, 2024	67,271,186
Dec 31, 2023	67,310,186
Sep 30, 2023	70,692,618
Jun 30, 2023	73,697,992
Mar 31, 2023	73,479,124
Dec 31, 2022	74,630,237
Sep 30, 2022	71,097,288
Jun 30, 2022	66,946,327
Mar 31, 2022	64,581,393
Dec 31, 2021	59,547,025
Sep 30, 2021	54,909,625
Jun 30, 2021	52,309,083
Mar 31, 2021	49,145,675
Dec 31, 2020	45,843,234
Sep 30, 2020	41,950,220
Jun 30, 2020	38,085,060
Mar 31, 2020	34,077,650
Dec 31, 2019	31,269,172
Sep 30, 2019	32,558,885
Jun 30, 2019	33,059,775
Mar 31, 2019	34,079,664
Dec 31, 2018	35,079,599
Sep 30, 2018	35,395,585
Jun 30, 2018	34,404,039
Mar 31, 2018	33,443,020
Dec 31, 2017	32,060,846
Sep 30, 2017	27,540,245
Jun 30, 2017	24,613,154
Mar 31, 2017	23,564,257
Dec 31, 2016	21,630,670
Sep 30, 2016	21,513,430
Jun 30, 2016	21,978,295
Mar 31, 2016	19,600,165
Dec 31, 2015	18,379,979
Sep 30, 2015	17,480,707
Jun 30, 2015	15,613,409
Mar 31, 2015	15,720,010
Dec 31, 2014	18,191,711
Sep 30, 2014	18,610,756
Jun 30, 2014	17,986,292
Mar 31, 2014	18,940,104
Dec 31, 2013	16,086,567
Sep 30, 2013	15,137,738
Jun 30, 2013	15,200,838
Mar 31, 2013	11,015,800
Dec 31, 2012	8,358,231
Sep 30, 2012	4,655,503
Jun 30, 2012	1,685,511
Mar 31, 2012	781,594
Dec 31, 2011	30,095
Sep 30, 2011	26,995
Jun 30, 2011	26,464
Mar 31, 2011	22,356
Dec 31, 2010	22,257
Sep 30, 2010	21,355
Jun 30, 2010	3,835,711
Mar 31, 2010	-16,180,862
Dec 31, 2009	-5,236,673
Sep 30, 2009	1,886,000
Jun 30, 2009	22,983,000
Mar 31, 2009	59,084,000
Dec 31, 2008	59,357,000
Jun 30, 2008	52,235,299
Mar 31, 2008	57,054,299
Dec 31, 2007	40,964,299
Sep 30, 2007	29,744,299
Jun 30, 2007	29,751,500